Skip to main content
NCBI home page
Springer logoLink to Springer
. 2011 Jun 7;54(8):2209. doi: 10.1007/s00125-011-2215-4

Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

Y Miao 1, D Dobre 1, H J Lambers Heerspink 1,✉, B M Brenner 2, M E Cooper 3, H-H Parving 4,5, S Shahinfar 6, D Grobbee 7, D de Zeeuw 1
PMCID: PMC3462989

Erratum to: Diabetologia

DOI 10.1007/s00125-010-1922-6

Unfortunately, the values for urinary ACR in the ‘Month 6 characteristics’ section of Table 1 were incorrect. They should have read 124 (46–249) for those in the group with serum potassium <5.0 mmol/l and 139 (51–291) for those in the group with serum potassium ≥5.0 mmol/l.

Footnotes

The online version of the original article can be found at 10.1007/s00125-010-1922-6.

Articles from Diabetologia are provided here courtesy of Springer

RESOURCES